Nantahala Capital Management, LLC 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO |
Nantahala Capital Management, LLC | 4,426,382 9.990% |
1,926,601 (+77.07%) |
Filing |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Nantahala Capital Management, LLC | 2,499,781 9.900% |
1,140,094 (+83.85%) |
Filing |
| 2023-02-14 5:05 pm Purchase |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Nantahala Capital Management, LLC | 1,359,687 7.900% |
1,359,687 (New Position) |
Filing |